Cooling Via Cryogenx Body Cooling Device
Launched by BRUNEL UNIVERSITY · Jul 18, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new cooling device called the CRYOGENX Cryosuit, which is designed to help cool down the body after exercise in hot conditions. Researchers want to see how quickly this device can cool the body compared to regular cooling methods, and they will measure how effective it is. The trial will include healthy adults aged 18 to 40 who exercise regularly, such as those who might be involved in sports or military training.
To participate, you need to be between 18 and 40 years old, in good health, and exercise at least three times a week. Unfortunately, if you are pregnant, have had issues with muscle fatigue or heat intolerance in the past, you won't be eligible to join. If you decide to take part, you will help researchers understand how well this cooling device works, which could benefit athletes and military personnel in the future. The trial is still in the planning stage and has not started recruiting participants yet.
Gender
ALL
Eligibility criteria
- The inclusion criteria are:
- • Aged 18 - 40 years Free from known injury, illness and disease and regular use of medications other than oral contraceptives Undertake exercise training \>3 times per week for \~30 minutes per session
- The exclusion criteria are:
- • Pregnant Previous history of neuromuscular fatigue Previous history of heat intolerance
About Brunel University
Brunel University is a distinguished research institution located in West London, renowned for its commitment to innovative education and cutting-edge research across various disciplines. As a clinical trial sponsor, Brunel University leverages its expertise in health sciences, engineering, and social sciences to conduct rigorous clinical research aimed at advancing medical knowledge and improving patient outcomes. The university fosters collaboration between academic researchers, healthcare professionals, and industry partners, ensuring that its clinical trials adhere to the highest ethical standards and regulatory requirements. Through its initiatives, Brunel University aims to contribute significantly to the development of new therapies and interventions that address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported